DOAJopen access
Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China
hepatitis c-chronic, cost-utility analysis, sofosbuvir/velpatasvir, sofosbuvir/ledipasvir, economic modeling, incremental cost-effectiveness ratio
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 20384
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.